findmyKOL

Lenard Adler, MD

Enriched profile

Carter A. Pottash Professor of Psychiatry; Professor of Child and Adolescent Psychiatry; Vice Chair of Education, Department of Psychiatry; Director, Adult ADHD Program, NYU Grossman School of Medicine · NYU Grossman School of Medicine

ORCIDNPI
Region🇺🇸 New York, NY · Northeast · United StatesSpecialtyPsychiatryFocusPsychiatry
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceverified 2026Payments2021–2021NIH fundingNone on fileWhy? →

Lenard Adler is Carter A. Pottash Professor of Psychiatry; Professor of Child and Adolescent Psychiatry; Vice Chair of Education, Department of Psychiatry; Director, Adult ADHD Program, NYU Grossman School of Medicine at NYU Grossman School of Medicine. OpenAlex indexes 318 publications with 21,711 citations (h-index 60); ClinicalTrials.gov lists 10 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Psychiatry profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Lenard Adler, MD, is Carter A. Pottash Professor of Psychiatry at NYU Grossman School of Medicine / NYU Langone Health, Department of Psychiatry. The public record shows 318 publications with 21,711 citations (h-index 60), centered on Psychiatry. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 2 companies.

  • Most recent indexed publication: 2024 · Journal of attention disorders
  • Top research focus: Psychiatry
  • 10 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 2 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Attention Deficit Disorder with Hyperactivity2 trials

Research focus

OpenAlex concept fingerprint
Psychiatry

Works with

trial sponsors and companies reporting payments
NYU Langone HealthClinical trials8Industry paymentsOtsuka Pharmaceutical Development & Commercialization, Inc.Clinical trialsIndustry payments3Chelsea TherapeuticsClinical trials1Industry payments

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
318publications

Distinct works indexed by OpenAlex, matched via ORCID; 6 in PubMed.

21,711citations

Total citations across indexed works.

60h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
10clinical trials

Investigator role on registered studies.

View trials
2companies · 2021–2021

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Public positions

sourced statements on record
  • Steering Committee member

    APSARD task force developing the first U.S. clinical guidelines for diagnosis and treatment of adult ADHD

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →apsard.org
  • Steering Committee member

    Adult ADHD Quality Measure Initiative

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com

Industry payments

Updated 27 Aug 2026

2 companies reported payments to CMS in program years 2021–2021. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    91.7%
    Central Nervous System Stimulant26.9%
    Vyvanse44%Dexmethylphenidate Hcl28%Dextroamphetamine Sulfate Er28%
    Part D<11 patients
    Benzodiazepine19.3%
    Clonazepam100%
    Part D<11 patients
  • Cardiovascular

    8.3%
    Central alpha-2 Adrenergic Agonist8.3%
    Guanfacine Hcl100%
    Part D<11 patients

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/lenard-adler-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • ResearchGate

    researchgate.net/profile/Lenard-Adler

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net
  • LinkedIn

    linkedin.com/in/lenardadler

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/NYULangone/videos/dr-lenard-adler-on-adhd/392294129241249

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com
  • Spotify

    open.spotify.com/episode/6aLZHTDcVSvPc5ZHEmGblB

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →open.spotify.com
  • X / Twitter

    x.com/nyulangone/status/1851071454726513069

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com
5 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board Certified

    American Board of Psychiatry & Neurology (Psychiatry)

    1986
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org
  • MD

    Emory University School of Medicine

    1982
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org
  • BA

    Economics, Cornell University College of Arts and Sciences

    1978
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →reachmd.com

Editorial & leadership roles

journal and society appointments
  • Director

    Adult ADHD Program, NYU Langone Health

    1995
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org
  • Vice Chair of Education

    Department of Psychiatry, NYU Grossman School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org
  • Past President

    American Professional Society of ADHD and Related Disorders (APSARD)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →reachmd.com
1 more role behind the reveal.Reveal →

Awards & honors

honors on the public record

Media & interviews

press, podcasts and appearances
2 more media items behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.